Cyclacel Pharmaceuticals Inc. logo

Cyclacel Pharmaceuticals Inc.

CYCCP | NASDAQ
Chart Builder DCF Calculator
$5.05
-$0.23 (-4.36%)
At close: Sep 11, 2025, 04:00 PM ET

Market Data

Market Cap
$11.31M
Enterprise Value
$7.52M
Beta
0.16
Average Volume
N/A
Shares Outstanding (Diluted)
5.6M
Shares Change YoY
253.46%
Institutional Ownership
N/A
Exchange
N/A
ISIN
N/A

Price Performance

Price Change 1M
N/A
Price Change 3M
N/A
Price Change 6M
N/A
Price Change YTD
N/A
Price Change 1Y
N/A
Price Change 3Y
N/A
Price Change 5Y
N/A
1M CAGR (ann.)
9.0%
1Y CAGR (ann.)
-21.1%
5Y CAGR (ann.)
8.3%
All-Time CAGR
10.7%

Valuation

PE Ratio
-1.39
Forward PE
0.01
PEG Ratio
0.02
Forward PEG
0.00
PS Ratio
6.08
Forward PS
0.10
PB Ratio
1.58
P/FCF Ratio
-10.30
P/Adj. FCF Ratio
-6.43
P/OCF Ratio
-4.63
EV/Sales
4.04
EV/EBIT
-2.75
EV/EBITDA
-2.75
EV/FCF
-6.85
Earnings Yield
-72.1%
FCF Yield
-9.7%
Adj. FCF Yield
-15.6%

Financial Health

Net Cash
$3.79M
Total Debt
$0
Cash & Short-Term Investments
$3.79M
Total Assets
$7.85M
Current Ratio
7.06
Quick Ratio
5.87
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
-252,378.33
Altman Z-Score
-71.51
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
19.3%
Operating Profit Margin
-147.1%
EBITDA Margin
301.7%
Net Profit Margin
-90302.0%
FCF Margin
-59.0%
Adj. FCF Margin
-94.6%
SBC / Revenue
125756.4%
SBC Impact (per share)
-60.3%

Returns

Return on Assets
-22.2%
Return on Equity
-39.0%
Return on Invested Capital
-33.0%
Return on Capital Employed
-33.6%
Return on Tangible Assets
-28.0%

Historical Growth (CAGR)

Revenue CAGR 3Y
70.9%
Revenue CAGR 5Y
72.3%
Revenue CAGR 10Y
2.2%
EPS CAGR 3Y
145.2%
EPS CAGR 5Y
57.9%
EPS CAGR 10Y
22.5%
FCF CAGR 3Y
73.2%
FCF CAGR 5Y
39.5%
FCF CAGR 10Y
0.7%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 9, 2025
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Cash Flow

Operating Cash Flow
$-1.1M
Free Cash Flow
$-1.1M
Adj. Free Cash Flow
$-1.76M
FCF Per Share
-$1.09
OCF Per Share
-$1.09
OCF/S Ratio
-327764.5%

Income Statement

Revenue
$1.86M
Gross Profit
$360K
Operating Income
$-2.74M
EBITDA
$-2.73M
Net Income
$-2.2M
EPS (Diluted)
-$3.64
Revenue / Employee
N/A
Profit / Employee
N/A
Employees
N/A

© 2026 bestshares.com. All rights reserved.